23andMe, a company that offers genetic testing services, announced Sunday that it has filed for bankruptcy protection. According to a March 23 press release, this move is part of a plan to sell its assets and restructure the business while continuing to operate, as the company faces financial difficulties.
“After a thorough evaluation of strategic alternatives, we have determined that a court-supervised sale process is the best path forward to maximize the value of the business,” said Mark Jensen, chair and member of the Special Committee of the Board of Directors.
He said that the company is committed to supporting its team members as well as protecting the privacy of customer data through this process….